Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Harkin student health bill

This article was originally published in The Tan Sheet

Executive Summary

A bill introduced March 6 by Sens. Tom Harkin, D-Iowa, and Lisa Murkowski, R-Alaska, would "update decades-old federal nutrition standards for snack foods sold in school cafeterias alongside the regular school meals," according to a press release. The "Child Nutrition Promotion and School Lunch Protection Act," S 2592, would also apply those standards to foods sold in vending machines on school grounds. USDA's current standards "limit the sale of so-called foods of minimal nutritional value and only apply to cafeterias during meal times," meaning unhealthy snack foods are available to students at other times of the day, a statement from the Center for Science in the Public Interest explains. Harkin has long championed increasing availability of health foods to students. In 2005, he unveiled legislation that would provide federal funding for fresh fruits and vegetables as free snacks in public schools (1"The Tan Sheet" July 25, 2005, p. 14)...

You may also be interested in...



Harkin Pushes For Supplement Food Stamp Coverage, Increased ODS Funding

Passage of a bill that would make dietary supplements eligible for food stamp coverage is a key item on Sen. Tom Harkin's (D-Iowa) legislative agenda

While Opening Dietary Ingredient Portfolio Wider, DuPont Opens Door On Online Supply Store

In its “robust, holistic hub” online, firms in the VMS product supply chain can determine their needs, “by product, solution or delivery formats,” and use a “comprehensive and unique portfolio” to “turn natural sources into shelf-ready products.”

Asia Deal Watch: Takeda, KSQ Take CRISPR Approach To T-Cell Oncology Therapy

Plus deals involving Astellas/Actinium, Sosei/PharmEnable, Aadi/EOC Pharma, BeiGene/Strand, Chi-Med/Inmagene, Alteogen/Intas, Sosei/AbbVie, Y-Biologics/3D Medicines.

Topics

UsernamePublicRestriction

Register

ID1132542

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel